Novel Concepts in Drug Delivery in Cancer Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 2
Special Issue Editor
Interests: phage assembly; phage-derived biotherapeutics; phage genomics; nanoparticle fractionation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The current special issue focuses on new approaches that might solve the key problems of anti-cancer chemotherapy. Problem #1 is that all chemotherapies have toxic side effects. Problem #2 is that, therefore, chemotherapies often cannot include drug levels high enough to kill tumors before they evolve drug resistance. In general, an obvious solution is to better target drugs to tumors. Implementation of this solution has often included use of a drug delivery vehicle (DDV). However, DDV-based strategies need improvement based on current outcomes. Other strategies, not yet widely considered, might be possible. This special issue is for manuscripts that either (1) improve or test DDV usage, and (2) propose or at least begin to implement alternative strategy. This special issue is NOT for finding of a new biochemistry-based anti-tumor drug target, because that is not a new problem-solving approach.
Prof. Dr. Philip Serwer
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery vehicles
- anti-cancer chemotherapy
- drug resistance
- cancer therapy
- innovative strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
